These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3415420)

  • 41. Improving treatment of urinary incontinence.
    Resnick NM
    JAMA; 1998 Dec; 280(23):2034-5. PubMed ID: 9863856
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma levels of oxybutynine chloride in children.
    Autret E; Jonville AP; Dutertre JP; Bertiere MC; Robert M; Averous M; Couet W
    Eur J Clin Pharmacol; 1994; 46(1):83-5. PubMed ID: 8005192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxybutynin and urinary incontinence.
    Castleden CM; Battcock TM; Duffin HM
    Age Ageing; 1990 Jan; 19(1):72-3. PubMed ID: 2316427
    [No Abstract]   [Full Text] [Related]  

  • 44. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of oxybutynin on the QTc interval in elderly patients with urinary incontinence.
    Hussain RM; Hartigan-Go K; Thomas SH; Ford GA
    Br J Clin Pharmacol; 1996 Jan; 41(1):73-5. PubMed ID: 8824696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Management of hyposalivation caused by oxybutynin chloride in the treatment of the unstable bladder].
    Arango Toro O; Nohales Taurines G; Cortadellas Angel R; Castro Santamaría R; Gelabert Mas A
    Actas Urol Esp; 1998 Feb; 22(2):124-30. PubMed ID: 9586268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preliminary evaluation of a new controlled-release oxybutynin in urinary incontinence.
    Radomski SB; Caley B; Reiz JL; Miceli PC; Harsanyi Z; Darke AC
    Curr Med Res Opin; 2004; 20(2):249-53. PubMed ID: 15006020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Oxybutynin-Kentera].
    Duh D; Vandevijver A
    J Pharm Belg; 2007; 62(3):99-100. PubMed ID: 17955962
    [No Abstract]   [Full Text] [Related]  

  • 49. Mechanical misadministration of an oral hypoglycemic agent.
    Schlozman SC; Hennessey JV
    Diabetes Care; 1997 Nov; 20(11):1796-7. PubMed ID: 9353626
    [No Abstract]   [Full Text] [Related]  

  • 50. [Adverse effects of oxybutynin chloride (Ditropan) in pediatrics].
    Jonville AP; Dutertre JP; Barbellion M; Autret E
    Arch Fr Pediatr; 1993 Jan; 50(1):27-9. PubMed ID: 8507135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxybutinin and the prevention of urinary incontinence in spina bifida.
    Hehir M; Fitzpatrick JM
    Eur Urol; 1985; 11(4):254-6. PubMed ID: 3899664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
    Von Zweigbergk M; Nordin B; Jonsson S
    Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514
    [No Abstract]   [Full Text] [Related]  

  • 53. Oxybutynin chloride combined with intermittent clean catheterization in the treatment of myelomeningocele patients.
    Mulcahy JJ; James HE; McRoberts JW
    J Urol; 1977 Jul; 118(1 Pt 1):95-6. PubMed ID: 327100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary incontinence in the elderly.
    Snustad DG; Rosenthal JT
    Am Fam Physician; 1985 Nov; 32(5):182-96. PubMed ID: 4061247
    [No Abstract]   [Full Text] [Related]  

  • 55. [Overdose of anticholinergic agents and confusional syndrome].
    Choulot JJ; Mensire A; Saint Martin J
    Ann Pediatr (Paris); 1989 Dec; 36(10):714. PubMed ID: 2624388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxybutynin therapy for generalized hyperhidrosis.
    Tupker RA; Harmsze AM; Deneer VH
    Arch Dermatol; 2006 Aug; 142(8):1065-6. PubMed ID: 16924061
    [No Abstract]   [Full Text] [Related]  

  • 57. Oxybutynin dependence: a case presentation.
    Mutlu EA
    Turk Psikiyatri Derg; 2011; 22(2):131-2. PubMed ID: 21780343
    [No Abstract]   [Full Text] [Related]  

  • 58. Oxybutynin administration diminishes the high gastric muscular tone associated with bladder reconstruction.
    Sheldon CA; Reeves D; Lewis AG
    J Urol; 1995 Feb; 153(2):461-2. PubMed ID: 7815620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional daytime incontinence: pharmacological treatment.
    Hjälmås K; Passerini-Glazel G; Chiozza ML
    Scand J Urol Nephrol Suppl; 1992; 141():108-14; discussion 115-6. PubMed ID: 1609246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of unstable bladder with oxybutynin hydrochloride. Our clinical experience in 80 cases].
    Alladio F; Arena G; Ferrando U; Pigato M; Sesia G
    Minerva Urol Nefrol; 1987; 39(4):359-62. PubMed ID: 3451374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.